Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
Early Phase 1
Completed
- Conditions
- Postpartum HemorrhageHigh Risk PregnancyCesarean Section
- Interventions
- Registration Number
- NCT04089176
- Lead Sponsor
- Rajavithi Hospital
- Brief Summary
Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section
- Detailed Description
Randomized controlled clinical trial. Defined patient in two group. Primary outcome is evaluate additional drug use Secondary outcome is evaluated estimated blood loss, hemoglobin level
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
- previous history of postpartum hemorrhage
- polyhydramnios
- fetal macrosomia
- previous cesarean section
- grand multiparity
- intramural myoma
- chorioamnionitis
- prolonged premature rupture of membrane
- augmentation of labour
Exclusion Criteria
- pregnancy induce hypertension
- on anticoagulant
- placenta previa or placenta percreta
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description protocal A Carbetocin Carbetocin versus placebo protocal B oxytocin Oxytocin versus placebo protocal A oxytocin Carbetocin versus placebo protocal B Carbetocin Oxytocin versus placebo
- Primary Outcome Measures
Name Time Method Additional drug use during intra-operation Number of additional drug use after intervention drug
- Secondary Outcome Measures
Name Time Method Side effect During intra-opeartion and acute post operation period as 24 hours post operation type of side effect
Estimate blood loss During intra-opeartion and acute post operation period as 24 hours post operation amount of blood loss
Hemoglobin level Pre-operation and 24 hours post operation differentiation of hemoglobin
Trial Locations
- Locations (1)
Rajavithi Hospital
🇹ðŸ‡Bangkok, Thailand